WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
102.92
-4.46 (-4.15%)
Sep 26, 2025, 3:00 PM CST
140.97%
Market Cap 299.67B
Revenue (ttm) 41.90B
Net Income (ttm) 13.77B
Shares Out 2.93B
EPS (ttm) 3.99
PE Ratio 22.60
Forward PE 21.69
Dividend 0.98 (0.95%)
Ex-Dividend Date Sep 26, 2025
Volume 48,528,522
Average Volume 64,605,121
Open 104.70
Previous Close 107.38
Day's Range 101.66 - 104.94
52-Week Range 41.50 - 115.79
Beta 0.75
RSI 48.92
Earnings Date Oct 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Sector Healthcare
Founded 2000
Employees 39,414
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial Statements

News

There is no news available yet.